Skip to main content

Table 2 Hematological data of the newborns with and without erythropoietin therapy

From: Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants

 

Treated group (n=21)

Non treated group (n=27)

Total (n=48)

p

 Volume of phlebotomy losses (ml/kg)*

16.8 [6.9 - 49.4]

14.5 [7.6 - 50.0]

15.1 [6.9 - 50.0]

0.7

 Start of iron supplementation (age in days)

22 [13 - 51]

20 [5 - 38]

20.5 [5 - 51]

0.5

Transfusions before day 15 of life

    

 Nb of infants transfused <D15**

9 (43 %)

5 (18 %)

14 (29 %)

0.07

 Transfusions per infant <D15

0 [0 - 2]

0 [0 - 1]

0 [0 - 2]

0.9

Transfusion after day 15 of life

    

 Nb of infants transfused ≥D15

7 (33 %)

9 (33 %)

16 (33 %)

1.00

 Transfusions per infant ≥D15

0 [0 - 3]

0 [0-2]

0 [0 - 3]

0.6

Day 0 of life

    

 Haemoglobin (g/dL)

15.2 [11.9-17.7]

15.9 [13.1-18.9]

15.5 [11.9-18.9]

0.2

2-3 wks

    

 Haemoglobin (g/dl)

11.4 [8.1-14.8]

11.3 [6.7-12.9]

11 [6.7 - 14.8]

0.9

 Age at sampling (d)

15 [14 - 21]

16 [14 - 21]

16 [14 - 21]

0.3

1 month of life

    

 Haemoglobin (g/dl)

9.9 [8.4 -12.8]

10.0 [8.1- 12.9]

10 [8.1 - 12.9]

0.7

 Age at sampling (d)

34 [29- 39]

32 [28- 39 ]

33 [28 - 39]

0.4

Discharge

    

 Haemoglobin (g/dl)

10.4 [7.7 -12.4]

9.6 [8.4- 11.7]

9.6 [7.7 - 12.4]

0.3

n=13

n= 21

n=34

 Age at sampling (d)

72 [43 - 99]

65 [46 - 93]

67 [43 - 99]

0.9

  1. *median [Min-Max], ** n (%).